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A B S T R A C T
Objective: To evaluate the results of the Protocol for treatment of patients with severe acute pancreatitis. Methods: We
consecutively analyzed age, gender, etiology, length of hospital stay, type of treatment and mortality of 37 patients with severe
acute pancreatitis from January 2002. Results: The patients’ ages ranged from 20 to 88 years (average 50 years), 27% were
female and 73% male. Mean overall hospital stay was 47 days. Thirteen patients were treated surgically, the average operations
per patient was two. There were six deaths among patients undergoing surgical treatment (46%) and two deaths in the group
submitted to medical treatment alone (8.3%). The overall mortality was 21%. Conclusion: After modification in the form of
management of patients with severe acute pancreatitis, there was a decrease in mortality and a trend for conservative
management.
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INTRODUCTION
Acute pancreatitis is a disease triggered by abnormalactivation of pancreatic enzymes and release of several
inflammatory mediators, whose etiology, in approximately
80% of cases, corresponds to biliary lithiasic disease or
alcohol ingestion1,2. The diagnosis obeys clinical, laboratory
and imaging parameters3. Most often, the disease is self-
limiting to the pancreas, with minimal systemic
repercussions; this mild form is characterized by good clinical
outcome and low mortality rates2. However, in
approximately 10% to 20% of the cases, the disease is
more intense, with great systemic effects, leading to levels
of up to 40% mortality.
After the Atlanta Symposium (1992)5, two clinical
well-defined acute pancreatitis became accepted: an interstitial
form (“light” or “edematous”) and asevere form, also known
as necro-hemorrhagic or “necrotizing”panvreatitis, that
usually implies some degree of pancreatic or peripancreatic
necrosis, or both, with more complications, such as necrosis
infection, peripancreatic fluid collections, abscesses,
pseudocysts, and even multiple organs failure.
According to the Study Group for the
Classification of Pancreatitis, severe acute pancreatitis (SAP)
is characterized by having three or more Ranson score
criteria, eight or more points in the APACHE II classification,
pancreatic complications or the presence of organ failure3.
Although less frequent, this severe form of the disease con-
tinues to generate a lot of controversy6, especially with
regard to the best treatment, becoming thus a challenge
for surgeons, physicians, radiologists, endoscopists and
intensivists7.
The goal of this series is to present the initial
results obtained with the Severe Acute Pancreatitis Care
Protocol in the Department of Surgical Gastroenterology
and Surgical Emergency Surgery, São Paulo Hospital 5
UNIFESP/EPM.
METHODS
We studied 37 patients consecutively admitted
to the Emergency Department of General Surgery, São
Paulo Hospital (HSP) and followed up at the Department
of Surgical Gastroenterology, diagnosed with severe acute
pancreatitis, respecting the criteria of the Atlanta
classification3, between January 2002 and December 2010.
We obtained information from each patient from medical
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records and analyzed the relationship of mortality with the
variables: age, gender, etiology, length of stay and type of
treatment.
For the analysis of treatment, patients were
divided into two groups. The first group included 13 patients
(group 1), 12 of which were submitted to surgical treatment
and one to percutaneous drainage of infected pancreatic
necrosis guided by imaging method. The indication of
surgical and percutaneous drainage was performed after
the diagnosis of sepsis in eight patients, and in five by gram
stainnig and culture of secretions obtained by fine needle
aspiration. In the second group, 24 patients clinically treated
according to the protocol were enrolled (group 2).
Statistical analysis was performed using the chi-
square, T-Student and Mann-Whitney tests. P-values   <0.05
were considered statistically significant.
RESULTS
The characteristics of variables analyzed are
shown in table 1.
The age of patients included in the study ranged
from 20 to 88 years (average 50). There was no statistically
significant difference in mortality (p=0.154). Ten patients
were female (27%) and 27 (73%) were male. Likewise,
there was no statistical significance for this variable with
respect to mortality (p=0.312 and p=0.359, respectively).
The etiology of acute pancreatitis in the present sample
was distributed as follows: in 22 (59.4%) patients, the cau-
se was biliary disease lithiasic; in nine (24.3%), the cause
was alcoholic; and in six (16.2%) patients the causal factor
could not determined. The etiology of pancreatitis was not
associated with mortality (p=0.617). The overall average
length of stay was 47 days. For group 1 patients, the length
of stay was 76 days (30-240 days), and for patients in group
2 it was 31.3 days (11-88 days). Statistical analysis revealed
no significance correlating this variable to mortality
(p=0.088). Overall mortality was 21.6% (8/37). Of the to-
tal deaths, six occurred in group 1 (46%) and only two
patients died in group 2 (8.3%).
The variable “type of treatment” reached the
higher statistical significance when the mortality in group 1
was correlated with the mortality in group 2 (p = 0.028).
DISCUSSION
In recent decades, several factors, such as
the progress of intensive care, imaging methods,
min imal ly  invas ive  procedures ,  spect rum and
pharmacokinetics of antibiotics and, crucially, a better
understanding of some pathophysiological aspects of
the disease, led to the increasing delay of surgical
intervention, with the consequent reduction in mortality
rates observed in SAP8.
Moreover, it has been repeatedly discussed how
to best characterize and early detect SAP. Laboratory
parameters and imaging scores such as APACHE II, Ranson
criteria, Glasgow, Goris, among others, have been
proposed6. However, there is still no consensus on the best
method, with a trend for less sophisticated and more
reproducible scores 9, such as Marshal and modified
sequential organ failure assessment (SOFA) 9.
Despite the defects in the existing Atlanta
classification 6, this remains a reference in the attempt to
standardize this characterization. For simplicity, we chose
to obey its guidelines in order to characterize SAP.
The epidemiological characteristics of the disease
appear to be well defined10, with variability only in the
etiologic factor according to the topographical area where
it is analyzed. The age and etiology in our sample did not
differ from other publications resulting from observed
samples11,12 in Brazil.   However, it is noteworthy the
predominance of male patients, perhaps attributable to the
small sample size.
Table 1 - Variables analyzed with respect to mortality.
Var iable Group 1 Group 2 p
Age 32-74 (43) 20-88 (51) 0.154
Gender 0.295
Male 10 17 -
Female 3 7 -
Et io logy 0.555
Biliary Tract 8 14 -
Alcohol 2 7 -
Indeterminate 3 3 -
Length of stay (30-240) 76 (11-88) 31.3 0.088
Type of treatment 13 24 0.028
Age = (Median)
Length of stay (days) = average
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Historically, the management of patients with SAP
has prompted discussion and debate about what would be
the best therapy 13. Conservative measures, based on
exclusively clinical supportive, differed immensely from
those proposing early surgical approach and even more
aggressive procedures, such as pancreatectomy 14. High
mortality rates led to abandon of the last two options
mentioned above.
Works such as the one from Mier et al. confirmed
that early operation in this patient carried a range of
complications and high rates of mortalidade15. This was
consolidated by better pathophysiological understanding of
the disease, allowing the SAP to be split into two phases,
the early, characterized by inflammatory dominance, the
and late – from the tenth day of illness on – a phase in
which patients can be affected by infectious complications16.
This is precisely one of the reasons why the papers
published from the 90’s clearly showed a tendency to
delayed surgery in patients with this indication17-19. The main
concern of this study was to analyze the approach of this
type of patient and associate it to clinical outcome.
There are studies that advocate the
postponement of surgery, at least until one has made all
attempts to compensate clinical situations and there are
no mandatory surgical or minimally invasive procedures
indications20-22. Clearly, due to the peculiar characteristics
of these patients, length of stay is usually prolonged, thus
reflecting increasing hospital costs. The length of stay of
patients in this series was higher in group 1, undergoing
surgical treatment (p <0.01), and although there have been
no cost analysis, it is likely to have been significantly higher
in this group.
In our study, the indication for surgical treatment
followed the Care Protocol, already mentioned, based on
the Atlanta criteria23. In this group, mortality rate,
considerably higher than in group 2, could be related to
severity, a fact demonstrated by longer hospital stays,
although stratification was not performed according to
severity.
Despite the small number of patients in our
sample, we can infer that the standardization of the initial
approach and the delayed surgical treatment of SAP
constitute the best alternative in order to improve the results
of this unique presentation of acute pancreatitis. Minimally
invasive methods, such as percutaneous, endoscopic and
laparoscopic, are gaining ground, with encouraging results
when compared to traditional methods in selected
patients24-26.
In conclusion, our study also confirms high rates
of mortality in patients with infected SAP undergoing
surgical treatment and shows a tendency towards
conservative management in this situation.
R E S U M O
Objetivo: Avaliar os resultados do Protocolo de Atendimento de pacientes com diagnóstico de pancreatite aguda grave. Méto-
dos: Foram analisados, consecutivamente, a partir de janeiro de 2002, idade, sexo, etiologia, tempo de internação, tipo de
tratamento e mortalidade de 37 pacientes portadores de pancreatite aguda grave. Resultados: A idade dos pacientes variou de
20 a 88 anos (média de 50 anos); 27% foram do sexo feminino e 73% do masculino. O tempo médio global de internação foi 47 dias.
Treze pacientes foram tratados cirurgicamente; a média de operações realizadas foi duas por paciente. Ocorreram seis óbitos
dentre os pacientes submetidos ao tratamento cirúrgico (46%) e dois óbitos no grupo submetido somente ao tratamento clínico
(8,3%). A mortalidade global foi 21% Conclusão: Após a modificação na forma de abordagem dos pacientes com pancreatite
aguda grave, houve diminuição da mortalidade e uma tendência para a conduta expectante.
Descritores: Pancreatite. Pancreatite necrosante aguda. Terapêutica. Cirurgia Geral. Mortalidade.
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